LAVONTE MCDANIEL: Open Payments
NPI 1023613247 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 17 payments from 4 companies in 2025. Trend: 2023 $16 · 2024 $168 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $248 |
| Neurocrine BioSciences, Inc. | 2 | $70 |
| Alkermes, Inc. | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: CAPLYTA, INGREZZA, ARISTADA, LYBALVI, REXULTI.
Industry payments across FL — which companies pay providers there.
